智能手机应用程序在2型糖尿病患者中促进身体活动的有效性:随机对照试验
Stephanie E Bonn1, Madeleine Hummel1, Giulia Peveri2,3
1Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Interactive journal of medical research
|March 21, 2024
概括
在6个月内,DiaCert移动健康应用程序在2型糖尿病患者中没有显著增加中度至剧烈的体力活动 (MVPA). 需要进一步的研究来确定有效的mHealth干预措施,为这一群体.
科学领域:
- 糖尿病管理 糖尿病管理
- 数字健康干预措施 数字健康干预措施
- 促进体育活动促进体育活动
背景情况:
- 身体活动可以改善2型糖尿病的血糖控制和心血管健康.
- 在初级保健中实施生活方式干预是具有挑战性的.
- 像DiaCert这样的移动健康 (mHealth) 应用程序可以支持身体活动.
研究的目的:
- 评估DiaCert应用程序在瑞典2型糖尿病患者中对中度至剧烈体力活动 (MVPA) 的3个月影响.
- 评估应用程序对6个月后MVPA的影响.
- 为了检查BMI,腰围,HbA1c,脂质和血压在3个月和6个月的变化.
主要方法:
- 181名患有2型糖尿病的参与者被随机分配到标准护理加DiaCert应用程序或单独标准护理.
- 使用加速度计测量了目标身体活动.
- 包括BMI,腰围,生物标志物和血压在内的结果在基线和随访时被评估.
主要成果:
- 干预组和对照组在3个月或6个月后没有观察到MVPA的显著差异.
- 没有发现对二次结果的显著影响,除了6个月后的边际BMI增加,这些BMI在不同组之间没有差异.
- 在这个队列中,DiaCert应用程序并没有导致增加身体活动水平.
结论:
- 在2型糖尿病患者中,DiaCert应用程序干预并没有增强MVPA.
- 该应用程序对BMI的影响是不确定的,对其他次要结果没有影响.
- 需要进一步研究有效的mHealth策略,以增加2型糖尿病患者的体力活动.
相关概念视频
01:36Carbohydrate Metabolism
11.1K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.1K
01:15Diabetes: Management and Pharmacotherapy
277
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
277